EC 35 (Atelvia risedronate sodium delayed-release 35 mg)
Generic Name: risedronate
Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Atelvia risedronate sodium delayed-release 35 mg. It is supplied by Allergan, Inc..
Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EC 35
Atelvia
- Generic Name:
- risedronate
- Imprint:
- EC 35
- Strength:
- risedronate sodium delayed-release 35 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Allergan, Inc.
- Inactive Ingredients:
- edetate disodium
ferric oxide yellow
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polysorbate 80
microcrystalline cellulose
dimethicone
sodium starch glycolate type A potato
stearic acid
magnesium silicate
triethyl citrate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3876 | Watson Pharmaceuticals, Inc. |
More about Atelvia (risedronate)
- Atelvia Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
Other brands: Actonel
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
